Increase Patient Adherence

24/7 Patient Support

Full Regulatory Compliance

Text To Speech Functionality

Extensive Cost Savings

Machine Learning Technology

Used by leading brands

UK’s No.1 infant colic treatment.

50 hours+ of regulatory reporting saved in 3 months.

UK's No.1 nappy rash treatment.

65% of user interactions between 1600 to 0800 hours.

Deployment for female contraception.

“Teva is delighted to be using VirtTuri with market-leading brands Sudocrem and Infacol. We’re seeing high levels of engagement and 24/7 accurate responses to our consumers.”

Nick Lang, Head of Teva UK & IE OTC Marketing


What is VirtTuri?

VirtTuri is a next generation AI avatar digital assistant that combines market-leading response speed and accuracy with a world-leading, patented, hyperrealistic avatar interface.

This combination is scientifically proven to elevate user engagement and recall of complex information.

Why VirtTuri?

As a visual interface tool, VirtTuri can enhance the behavioural learning process by up to 400%.

VirtTuri mines deep patient and consumer behaviour insights for enhanced strategy.

VirtTuri delivers holistic assistance and support to user pathways.

VirtTuri can represent multiple ethnicities, ages and speak over 50 languages.

Text to speech technology allows for cost effective, rapid updates.

VirtTuri is GDPR and regulatory compliant.

Where can VirtTuri be used?

Example digital platform deployments in healthcare and fast-moving consumer goods:

Delivering consistent information at scale

VirtTuri is relevant to all industries and organisations seeking solutions for cost effective, digital communications, at scale.

Right now, we’re keen to explore opportunities across healthcare, education, consumer goods, HR & training, telecoms, financial and public notices.

We're Hiring!

Machine Learning Data Scientist

Computer Vision Scientist

Please send any questions or CVs to: and


Sacle Up Programme
Cardiff University
Gov Department for International Trade
University of Essex


    Telephone: +44 (0) 203 411 9111


    Press enquiries: +44 (0) 7545 342737